Recent Company News

• 10:07 AM ET Jul 01, 2026
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (208 total)

• 10:00 AM ET Jun 26, 2026
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (246 total)

• 11:24 AM ET Jun 25, 2026
  

  StreetAccount Summary - US unusual volume traders

• 10:01 AM ET Jun 25, 2026
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (324 total)

• 06:07 AM ET Jun 24, 2026
  

  Silence Therapeutics initiated overweight at Cantor Fitzgerald ($7.27, 0.00)

• 07:32 AM ET Jun 11, 2026
  

  Silence Therapeutics presents follow-up and quality-of-life data from the Phase 1 SANRECO study evaluating divesiran ($6.00, 0.00)

• 05:45 PM ET Jun 03, 2026
  

  Transcript Intelligence: Silence Therapeutics at Jefferies Global Healthcare Conference ($6.41, +0.04)

• 08:53 AM ET May 28, 2026
  

  StreetAccount Summary - US Initial Syndicate recap for 28-May

• 04:59 PM ET May 27, 2026
  

  Silence Therapeutics enters Open Market Sale Agreement for up to $100M - 424B5

• 02:33 PM ET May 19, 2026
  

  Transcript Intelligence: Silence Therapeutics at H.C. Wainwright BioConnect Investor Conference ($5.92, -0.32)